» Articles » PMID: 20307352

The Influence of Maternal Glycaemia and Dietary Glycaemic Index on Pregnancy Outcome in Healthy Mothers

Overview
Journal Br J Nutr
Date 2010 Mar 24
PMID 20307352
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Infant birth weight has increased in Ireland in recent years along with levels of childhood overweight and obesity. The present article reviews the current literature on maternal glycaemia and the role of the dietary glycaemic index (GI) and its impact on pregnancy outcomes. It is known that maternal weight and weight gain significantly influence infant birth weight. Fetal macrosomia (birth weight >4000 g) is associated with an increased risk of perinatal trauma to both mother and infant. Furthermore, macrosomic infants have greater risk of being obese in childhood, adolescence and adulthood compared to normal-sized infants. There is evidence that there is a direct relationship between maternal blood glucose levels during pregnancy and fetal growth and size at birth, even when maternal blood glucose levels are within their normal range. Thus, maintaining blood glucose concentrations within normal parameters during pregnancy may reduce the incidence of fetal macrosomia. Maternal diet, and particularly its carbohydrate (CHO) type and content, influences maternal blood glucose concentrations. However, different CHO foods produce different glycaemic responses. The GI was conceived by Jenkins in 1981 as a method for assessing the glycaemic responses of different CHO. Data from clinical studies in healthy pregnant women have documented that consuming a low-GI diet during pregnancy reduces peaks in postprandial glucose levels and normalises infant birth weight. Pregnancy is a physiological condition where the GI may be of particular relevance as glucose is the primary fuel for fetal growth.

Citing Articles

Acceptability and feasibility of a planned preconception weight loss intervention in women with long-acting reversible contraception: the Plan-it mixed-methods study.

Channon S, Coulman E, Cannings-John R, Henley J, Lau M, Lugg-Widger F Health Technol Assess. 2023; 27(1):1-224.

PMID: 36688498 PMC: 9885302. DOI: 10.3310/NKIX8285.


Low-Protein Infant Formula and Obesity Risk.

Kouwenhoven S, Muts J, Finken M, van Goudoever J Nutrients. 2022; 14(13).

PMID: 35807908 PMC: 9268498. DOI: 10.3390/nu14132728.


Associations of maternal early-pregnancy dietary glycemic index with childhood general, abdominal and ectopic fat accumulation.

Wahab R, Jaddoe V, Gaillard R Clin Nutr. 2021; 40(4):1628-1636.

PMID: 33752151 PMC: 7613756. DOI: 10.1016/j.clnu.2021.02.046.


An update on the use of inositols in preventing gestational diabetes mellitus (GDM) and neural tube defects (NTDs).

Facchinetti F, Cavalli P, Copp A, DAnna R, Kandaraki E, Greene N Expert Opin Drug Metab Toxicol. 2020; 16(12):1187-1198.

PMID: 32966143 PMC: 7614183. DOI: 10.1080/17425255.2020.1828344.


Maternal early pregnancy dietary glycemic index and load, fetal growth, and the risk of adverse birth outcomes.

Wahab R, Scholing J, Gaillard R Eur J Nutr. 2020; 60(3):1301-1311.

PMID: 32666314 PMC: 7987612. DOI: 10.1007/s00394-020-02327-9.